AI in Pharmaceutical Market Scope
The pharmaceutical industry is considered in one of the major industries which are intended for the use of artificial intelligence, the major reason behind the adoption of AI in this industry is its wide range of applications. In this sector, machine learning helps in enhance marketing, manufacturing, and drug trials. And artificial intelligence operates as a machine learning system, continuously responding and analyzing data, that allows researchers to collect information effectively.
The market study is being classified, by Application (Neurodegenerative Diseases, Immuno-Oncology and CVD) and major geographies with country level break-up.
The market is fragmented by the leading players across the globe, those are focusing on production technologies, and highly investing in research on development for the improvement of efficiency and service life. With the growing opportunities is captured by tracking the ongoing process improvement and financial flexibility to invest in market growth strategies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global AI in Pharmaceutical market throughout the predicted period.
AbbVie (United States), Almirall (Spain), Amgen (United States), Astellas (Japan), AstraZeneca (United Kingdom), BASF (Germany), Bayer (Germany), Boehringer Ingelheim (Germany), Bristol-Myers Squibb (BMS) (United States), CJ Healthcare (South Korea) and Celgene (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Daewoong Pharmaceutical (South Korea), Eisai (Japan) and Eli Lilly (United States).
AdvanceMarketAnalytics has segmented the market of Global AI in Pharmaceutical market by Type, Application and Region.
On the basis of geography, the market of AI in Pharmaceutical has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
- Rapid Adoption of Machine Learning from the Research Centers & Pharmaceutical Companies
- Increasing Number of Cross-Industry Partnerships and Partnerships
- Rising Concern Regarding Control Drug Discovery & Development Costs and Reduce Time
- Increasing Number of Patent Expiry
- Development in Biotechnology Industry
- High Growth in the Healthcare Industry
- Restricted Availability of Technology Approvals
Key Target AudienceVenture Capitalists and Private Equity Firms, New Entrants/Investors, Analyst and Strategic Business Planners, AI in Pharmaceutical Service Providers, Government Regulatory and Research Organizations and End-Use Industries
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase